Voyager Therapeutics (VYGR)
(Real Time Quote from BATS)
$8.52 USD
-0.28 (-3.18%)
Updated Jun 14, 2024 10:50 AM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Brokerage Reports
Voyager Therapeutics, Inc. [VYGR]
Reports for Purchase
Showing records 21 - 40 ( 145 total )
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Making It Official - VYGR Appoints Al Sandrock To CEO Role
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Additional TRACER Licensing Deal Extends Cash Runway
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
CFO Dorval To Depart, Still Awaiting More Clarity on Path Forward
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
PFE Collaboration Brings Non-Dilutive Cash For TRACER
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
When One Door Closes, Another Opens - Management Changes Announced At VYGR
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Huntington''s Efforts On Track, Partnering Parkinson''s Programs
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Heading Into Clinic With VY-HTT01 - FDA Clears Hold, IND
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Holding On - With VYGR Working To Address Clinical Pauses, Uneventful 4Q20
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
NBIX Parts Ways With VYGR Parkinson''s Gene Therapy; Moving To Neutral on VYGR
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Making It Official - FDA Places Clinical Hold On RESTORE-1
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
VY-AADC/NBIb-1817 Hits The Pause Button As DSMB Conducts Safety Review
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L